Neutral editorial coverage examining institutional commentary, healthcare sector context, and index association surrounding a respiratory medical technology provider within established United States ...
Shares in ResMed Inc. experienced a significant surge, rising 5.2 per cent in morning trade following the release of its ...
A busy week of quarterly results delivered regulatory milestones, broker upgrades and mixed share-price moves across ASX ...
Stockhead on MSN
Closing bell: ASX stumbles as commodity rally takes a walloping
The ASX was put into reverse on Friday, plunging 0.65% against a backdrop of sharply declining metals prices and falling ...
Masks and accessories were the standout growth category for Resmed in the second quarter of its fiscal year 2026, with the company reporting a 16% increase in revenue in the United States, Canada and ...
Revenue increased by 11% to $1.4 billion; up 9% on a constant currency basis Gross margin up 320 bps to 61.8%; non-GAAP gross margin up 310 bps to 62.3%Income from operations increased 18%; non-GAAP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results